Search Results - Daniel A. Pryma

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    PARP1-targeted alpha therapy enhances target expression by Hasan Babazada, Paul Martorano, Hsiaoju Lee, Shuyao Geng, Vandana Batra, John M. Maris, Daniel A. Pryma, Sarah B. Gitto, Michael D. Farwell

    Published in EJNMMI Research (2025-06-01)
    Get full text
    Article


  2. 2

    [18F]FluorThanatrace PET imaging as a biomarker of response to PARP inhibitors in breast cancer by Sarah B. Gitto, Austin R. Pantel, Kara N. Maxwell, Daniel A. Pryma, Michael D. Farwell, Fang Liu, Quy Cao, Sophia R. O’Brien, Amy S. Clark, Payal D. Shah, Elizabeth S. McDonald

    Published in Communications Medicine (2025-03-01)
    Get full text
    Article


  3. 3

    A biorthogonal chemistry approach for high-contrast antibody imaging of lymphoma at early time points by Swarbhanu Sarkar, Jonathan M. Pham, Kimberly J. Edwards, Nitika Sharma, Kexiang Xu, A. Paden King, Andres Fernandez del Castillo, Michael D. Farwell, Daniel A. Pryma, Stephen J. Schuster, Mark A. Sellmyer

    Published in EJNMMI Research (2025-03-01)
    Get full text
    Article


  4. 4

    Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma by Mehran Makvandi, Minu Samanta, Paul Martorano, Hwan Lee, Sarah B. Gitto, Khushbu Patel, David Groff, Jennifer Pogoriler, Daniel Martinez, Aladdin Riad, Hannah Dabagian, Michael Zaleski, Tara Taghvaee, Kuiying Xu, Ji Youn Lee, Catherine Hou, Alvin Farrel, Vandana Batra, Sean D. Carlin, Daniel J. Powell, Robert H. Mach, Daniel A. Pryma, John M. Maris

    Published in Communications Biology (2022-11-01)
    Get full text
    Article


Search Tools: